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EGF receptor kinase activity is required for gap junction closure
and for part of the decrease in ovarian follicle cGMP in response
to luteinizing hormone.
Rachael P Norris1, Marina Freudzon1, Viacheslav O Nikolaev2, and Laurinda A Jaffe1
1Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06032,
USA
2Institute of Pharmacology and Toxicology, University of Würzburg, D-97078 Würzburg, Germany
Abstract
The meiotic cell cycle in mouse oocytes is arrested in prophase, and then restarted when
luteinizing hormone (LH) acts on the surrounding granulosa cells. The granulosa cells keep
meiosis arrested by providing a source of cGMP that diffuses into the oocyte through gap
junctions, and LH restarts the cell cycle by closing the junctions and by decreasing granulosa cell
cGMP, thus lowering oocyte cGMP. Epidermal growth factor receptor (EGFR) activation is an
essential step in triggering LH-induced meiotic resumption, but its relationship to the cGMP
decrease in the follicle is incompletely understood, and its possible function in causing gap
junction closure has not been investigated. Here we use EGFR agonists (epiregulin and
amphiregulin), and an EGFR kinase inhibitor (AG1478) to study the function of the EGFR in the
signaling pathways leading to the release of oocytes from prophase arrest. Our results indicate that
the EGFR kinase contributes to LH-induced meiotic resumption in two different ways. First, it is
required for gap junction closure. Second, it is required for an essential component of the decrease
in follicle cGMP. Our data show that the EGFR kinase-dependent component of the cGMP
decrease is required for LH-induced meiotic resumption, but they also indicate that an as yet
unidentified pathway accounts for a large part of the cGMP decrease.
Introduction
The mammalian ovarian follicle is comprised of multiple layers of granulosa cells enclosing
a central oocyte, which is arrested in prophase of meiosis until luteinizing hormone (LH)
acts on the outer granulosa cells to restart the cell cycle (Eppig et al. 2004; Jaffe & Norris
2010). In the mouse preovulatory follicle, all of the granulosa cells, and the oocyte, are
interconnected by gap junctions (see Norris et al. 2008), and the presence of the granulosa
cells with open gap junctions is essential for maintaining the oocyte in meiotic prophase
arrest. If the oocyte is removed from the follicle (Pincus & Enzmann 1935), or if the gap
junctions are closed pharmacologically (Piontkewitz & Dekel 1993; Sela-Abramovich et al.
2006; Norris et al. 2008), the oocyte resumes meiosis.
The gap junctions provide a direct connection by which cyclic GMP enters the oocyte from
the granulosa cells, and in the oocyte cGMP inhibits phosphodiesterase 3A, thus keeping
cAMP high and maintaining meiotic arrest (Norris et al. 2009; Vaccari et al. 2009). cAMP
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is generated in the oocyte by a constitutively active Gs-linked receptor, GPR3 in mice or
GPR12 in rats (Mehlmann et al. 2004; Mehlmann 2005; Ledent et al. 2005; Hinckley et al.
2005). High cAMP in the oocyte maintains meiotic arrest at least in part by activating
protein kinase A, which phosphorylates the phosphatase CDC25B; this results in
sequestration of CDC25B in the cytoplasm, such that it cannot dephosphorylate and activate
the kinase CDK1 in the nucleus, which directly controls the prophase-to-metaphase
transition (see Oh et al. 2010). CDK1 activity also depends on a regulatory cyclin B1
subunit, and by unknown means, high cAMP prevents the accumulation of cyclin B1 in the
nucleus (Marangos & Carroll 2004; Holt et al. 2010).
LH receptor activation in the outer granulosa cells acts to reverse the inhibition of CDK1 in
the oocyte, by reducing the influx of cGMP from the granulosa cells into the oocyte. LH
reduces cGMP influx both by causing the gap junctions to close (Sela-Abramovich et al.
2006; Norris et al. 2008) and by causing cGMP in the granulosa cells to decrease (Norris et
al. 2009; Vaccari et al. 2009; see also Davis et al. 1986; Hubbard 1986; Törnell et al. 1991).
Both of these LH actions have the consequence of lowering cGMP in the oocyte, thus
lowering cAMP, activating CDK1, and restarting the meiotic cell cycle, which is
characterized by the breakdown of the nuclear envelope between 2 and 4 hours after LH
exposure. LH acts on a G-protein-coupled receptor (see Jaffe and Norris, 2010), but how this
results in gap junction closure and the cGMP decrease in the mouse ovarian follicle is not
well understood.
One important link between LH receptor activation in the outer granulosa cells and meiotic
resumption in the oocyte is the rapid synthesis (Park et al. 2004) and proteolytic release
from the granulosa cell surface (Ashkenazi et al. 2005; Panigone et al. 2008; Andric &
Ascoli 2008) of the epidermal growth factor receptor (EGFR) ligands epiregulin and
amphiregulin. EGFR kinase activity in the follicle increases by 30 minutes after LH
application (Panigone et al. 2008). Treatment of isolated follicles with EGFR ligands causes
meiosis to resume (Dekel & Sherizly 1985; Park et al. 2004; Ashkenazi et al. 2005), and
AG1478, which inhibits EGFR kinase activity (Levitzki & Gazit 1995; Panigone et al.
2008), inhibits meiotic resumption in response to LH (Park et al. 2004; Ashkenazi et al.
2005). In addition, follicles from mice that express a mutated EGFR kinase with reduced
activity, or that lack the EGFR ligands epiregulin or amphiregulin, show reduced meiotic
resumption in response to LH (Hsieh et al. 2007). EGF receptors are located on both mural
granulosa and cumulus cells, but not on the oocyte (Downs et al. 1988; Park et al. 2004;
Panigone et al. 2008; Su et al. 2010), supporting the concept that the release of epiregulin
and amphiregulin from the outer granulosa cells where the LH receptors are located,
functions to propagate the LH signal into the follicle interior.
A previous study has shown that activation of the EGF receptor with amphiregulin or
epiregulin lowers granulosa cell cGMP, and that the decrease in granulosa cell cGMP in
response to LH can be reduced by inhibiting the EGFR kinase with AG1478 (Vaccari et al.
2009). Here we further investigate the function of the EGFR kinase in causing the cGMP
decrease, and also examine its function in causing gap junction closure. Our data indicate
that while EGFR kinase activity is required for the LH-induced closure of gap junctions, an
as yet unidentified pathway accounts for a large part of the cGMP decrease. However, the
EGFR kinase-dependent component of the cGMP decrease is required for LH-induced
meiotic resumption.
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Results and Discussion
Magnitude and time course of the cGMP decrease in response to LH
Two previous studies have shown that cGMP in isolated mouse follicles decreases in
response to LH, but the basal cGMP concentrations and the magnitudes of the decrease
differed (Norris et al. 2009; Vaccari et al. 2009). Therefore, to establish a baseline for
subsequent experiments, we determined the magnitude and time course of the cGMP
decrease upon LH application for the experimental conditions used here. Measurements
were made using an ELISA method, and concentrations were calculated using an estimated
value of 20 nl for the cellular volume of an isolated follicle (see Materials and Methods).
Because the volume was not known exactly, the following concentrations should be
considered approximations. The mean value for basal cGMP was ~3 μM, and this decreased
to ~500 nM at 20 minutes after LH application; cGMP then continued to decrease, reaching
~100 nM at 1 hour, and ~30 nM at 5 hours (Fig. 1).
The measurements reported here, as well as those in our previous study (Norris et al. 2009)
indicate that at 1 hour after LH application, GMP has decreased to ~4% of the basal level,
whereas another study (Vaccari et al. 2009) reported a smaller decrease, to 39%. In addition,
while we found that most of the cGMP decrease had occurred by 20 min after LH
application, Vaccari et al. first detected the cGMP decrease at 1 hour, with no change seen at
30 min. Interestingly, a study of rat granulosa cells in primary culture showed a decrease in
cGMP as early as 3 min after applying LH (Davis et al. 1986).
Activation of the EGFR causes a decrease in follicle cGMP
To investigate to what extent the EGFR kinase contributes to the LH-induced decrease in
follicle cGMP, we first measured cGMP in response to an EGFR ligand. The concentrations
of epiregulin and amphiregulin proteins in the extracellular space of the follicle after LH
exposure are unknown, so we used a concentration of epiregulin (100 nM) that has been
previously found to maximally stimulate nuclear envelope breakdown when applied to
isolated follicles (Park et al. 2004). We confirmed the previous finding that 100 nM
epiregulin stimulates meiotic resumption to the same extent as LH (Fig. 2). Approximately
90% of oocytes underwent nuclear envelope breakdown by 4 hours.
Some but not all of the cGMP decrease that occurred in response to LH also occurred when
follicles were treated with epiregulin. The mean concentration of cGMP was ~600 nM
following a 1 hour treatment with 100 nM epiregulin, vs ~100 nM cGMP in response to LH
(Fig. 3A).
The EGFR kinase inhibitor AG1478 only partially inhibits the cGMP decrease in response
to LH
To examine whether EGFR kinase activation is required for LH stimulation of the cGMP
decrease, we used the selective EGFR kinase inhibitor AG1478. In vitro, AG1478 inhibits
EGFR kinase activity with an IC50 of 3 nM (Levitzki & Gazit 1995). In follicles stimulated
with LH, 500 nM AG1478 completely inhibits LH-induced EGFR phosphorylation on
tyrosine 1068, one of several tyrosines that are phosphorylated in response to EGFR
activation; this indicates that LH does not detectably increase EGFR activation under these
conditions (Panigone et al. 2008).
As previously reported (Park et al. 2004; Ashkenazi et al. 2005), AG1478 had an inhibitory
effect on nuclear envelope breakdown in response to LH. Under our conditions, 500 nM
AG1478 completely inhibited nuclear envelope breakdown in response to LH when
observed at 6 hours, although ~30% of oocytes had resumed meiosis when observed at 20
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hours (Fig. 2B). The meiosis-inhibitory effect of AG1478 is on signaling in the granulosa
cells, rather than the oocyte, since AG1478 does not inhibit spontaneous meiotic resumption
in isolated oocytes (Park et al. 2004, and Fig. S1).
500 nM AG1478 had only a partial inhibitory effect on the LH-induced cGMP decrease
(Fig. 3A). At one hour after applying LH in the presence of AG1478, cGMP had decreased
to ~500 nM, corresponding to ~15% of the basal level. This was significantly different from
the ~100 nM level attained at 1 hour after LH in the absence of AG1478. However, the
presence of AG1478 did not restore cGMP to the basal level of ~3 μM measured in the
absence of LH; the values for the basal cGMP concentration and that at 1 hour after LH +
500 nM AG1478 were significantly different (see legend for Fig. 3A).
The incomplete inhibition of the LH-induced cGMP decrease by AG1478 did not appear to
be due to incomplete inhibition of the EGFR kinase activity, since 500 nM AG1478
prepared from the same stock solution as used for the cGMP measurements reduced LH-
stimulated phosphorylation of the EGFR on tyrosine 1068 to a level that was
indistinguishable from the basal level without LH (Fig. 3B). Thus, although epiregulin is
sufficient to cause ~80% of the cGMP decrease in the follicle in response to LH, EGFR
activity is not required for most of the LH-induced cGMP decrease. These findings support
the concept that 2 separate and partially redundant mechanisms contribute to the decrease in
cGMP in response to LH.
Inhibition of the activation of MAP kinase with U0126 has no inhibitory effect on the cGMP
decrease in response to LH
One important consequence of EGFR kinase activation in the ovarian follicle is the
activation of MAP kinase (Panigone et al. 2008). Therefore, we investigated the effect of
inhibiting MAP kinase activation on the LH-induced cGMP decrease in the follicle. To do
this, we used U0126, an inhibitor of the kinase (MAP kinase kinase, or MEK) that activates
MAP kinase. 10 μM U0126, which has previously been demonstrated to fully inhibit MAP
kinase activation in response to LH (Norris et al. 2008), did not have any inhibitory effect
on the cGMP decrease in response to LH (Fig. 3A). Thus the cGMP decrease in response to
LH, including its EGFR kinase-dependent component, occurs by a pathway other than MAP
kinase activation. In contrast, 10 μM U0126 completely inhibits gap junction closure in
response to LH (Norris et al. 2008).
Activation of the EGFR causes gap junction closure
To investigate whether gap junction closure in response to LH is mediated by activation of
the EGFR kinase, we first compared gap junction permeability after applying epiregulin or
LH. Gap junction permeability was assessed by injecting a fluorescent tracer into the oocyte,
and 20 min later, measuring the ratio of fluorescence in the mural granulosa cells over that
in the inner cumulus cells (Norris et al. 2008). Compared to the ratio in untreated follicles,
one hour treatments with LH and 100 nM epiregulin caused decreases to 9 and 32% of the
basal level, respectively (Fig. 4). Even when the concentration of EGFR agonist was
increased 20 times, by applying 1 μM epiregulin + 1 μM amphiregulin, gap junction closure
was less complete than that observed with LH application (Fig. 4), but it is unknown how
well externally applied EGFR agonists penetrate throughout the follicle. Our results suggest
that the stimulation of meiotic resumption by externally applied EGFR ligands (see
Introduction and Fig. 2) is a consequence of partial closure of gap junctions and a partial
decrease in granulosa cell cGMP, acting together to lower oocyte cGMP.
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The EGFR kinase inhibitor AG1478 inhibits gap junction closure in response to LH
We next examined the effect on LH-induced gap junction closure of inhibiting the EGFR
kinase with AG1478. In the presence of 500 nM AG1478, gap junction permeability after
LH application was indistinguishable from that in an untreated follicle (Fig. 4). It should be
noted however, that partial closure of gap junctions might not have been detected by the
method used here. These results indicate that EGFR activation is an essential factor in
causing gap junction closure in response to LH, but leave open the possibility that other
signaling pathways contribute as well. The conclusion that EGFR activation is an important
factor in causing gap junctions to close in response to LH is supported by a recent report that
ovaries from mice with reduced EGFR activity show reduced phosphorylation of connexin
43 in response to LH (Andric et al. 2010).
An alternative interpretation of these results is that non-specific effects of AG1478 could
contribute to its inhibitory effect on gap junction closure (and on the cGMP decrease). An
extensive characterization of the specificity of AG1478 has not been previously published,
but information on this question was made available by the National Centre for Protein
Kinase Profiling (MRC Protein Phosphorylation Unit, University of Dundee, Scotland, UK).
The IC50 for AG1478 was >1 μM for 101 out of the 110 kinases tested (see Supplementary
Table 1). Although in vivo inhibitory concentrations cannot be predicted from the in vitro
data, the in vitro inhibitory concentrations for all of these other kinases were much greater
than for that the EGFR (IC50 = 3 nM, Levitzki & Gazit 1995). Importantly, the MAP kinases
ERK1 and ERK2 were not inhibited by AG1478. Thus, although non-specific effects have
not been absolutely excluded, the actions of 500 nM AG1478 on the LH-induced gap
junction closure and follicle cGMP decrease are most likely due to inhibition of the EGFR
kinase.
Comparison with previous studies
The results described here indicate that the EGFR kinase contributes to LH-induced meiotic
resumption both by causing gap junction closure, and by causing an essential component of
the decrease in follicle cGMP. They also indicate that an as yet unidentified pathway
accounts for a large part of the cGMP decrease. Although this and a previous study (Vaccari
et al. 2009) both support the conclusion that the EGFR kinase has a role in causing the
cGMP decrease in response to LH, the two studies differ on the issue of whether EGFR
activation is solely responsible. While we found that 500 nM AG1478 had only a partial
inhibitory effect on the cGMP decrease, the Vaccari et al. study reported that at 500 nM,
AG1478 completely inhibited the cGMP decrease in response to LH.
The causes of the differences in some of the results reported here and by Vaccari et al. are
unknown, but differences in the strain of mouse, the methods of follicle culture, and/or other
methodological differences could be critical. One possible factor is that the mean value for
basal cGMP reported here (~60 fmol/follicle) was somewhat greater than that in the Vaccari
et al. study (~18 fmol/follicle), possibly due to the method of sample preparation. While
Vaccari et al. froze the follicles, and only after defrosting processed them to inactivate
cGMP phosphodiesterases, we prepared samples from unfrozen follicles. In preliminary
experiments in which we used frozen follicles, our measurements of basal cGMP were
~10% of the values obtained in subsequent experiments with follicles processed without
prior freezing (see Fig. S2 in the Supplementary Materials). Possible loss of cGMP during
sample processing could contribute to why Vaccari et al. observed complete inhibition of
the LH-induced cGMP decrease by AG1478. If a non-EGFR kinase-dependent cGMP
decrease occurred during sample preparation, it could mask a non-EGFR kinase-dependent
component of the cGMP decrease that occurs in response to LH. Likewise, such an effect
could contribute to the smaller percent decrease in follicle cGMP in response to LH reported
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by Vaccari et al., and to why an early decrease in cGMP was not detected. Other unknown
factors may also be important.
Despite these differences, our data support the general conclusion that EGFR signaling is
important for both pathways leading to meiotic resumption in response to LH. The
physiological significance of the EGFR kinase-dependent component of the cGMP decrease
is indicated by comparing the effects of U0126 and AG1478 on responses to LH. The two
inhibitors both prevent gap junction closure (Fig. 4, and Norris et al. 2008), but only
AG1478 has an inhibitory effect on the cGMP decrease (Fig. 3A). Correspondingly, LH
causes meiotic resumption in the presence of U0126 (Su et al., 2003; Norris et al. 2008), but
not in the presence of AG1478 (see Introduction and Fig. 2). Thus, to decrease cGMP
sufficiently to cause meiotic resumption, EGFR signaling is essential.
Unanswered questions
Activation of MAP kinase causes the closure of gap junctions in response to LH, by
phosphorylating connexin 43 (Sela-Abramovich et al. 2005; Norris et al. 2008), and MAP
kinase activation in the follicle in response to LH depends strongly, but not entirely, on
EGFR kinase activity (Panigone et al. 2008). Likewise, connexin 43 phosphorylation
depends strongly on EGFR kinase activity (Andric et al. 2010). These results indicate that
the EGFR kinase acts to cause gap junction closure by initiating a signaling pathway that
results in MAP kinase phosphorylation of connexin 43. However, MAP kinase activation
does not account for the cGMP decrease in response to LH-induced EGFR activation, since
the LH-induced decrease in cGMP in the follicle occurs independently of MAP kinase. It
remains to be determined how other consequences of EGFR kinase activation contribute to
the cGMP decrease in the follicle (Fig. 5).
Our findings support the conclusion that pathways other than EGFR kinase activation also
function to cause the LH-induced cGMP decrease in the follicle. In particular, while the LH-
induced rise in cAMP in the mural granulosa cells leads to EGFR activation (Panigone et al.
2008), cAMP elevation may have other EGFR-independent effects. It also remains to be
determined whether other EGFR-independent consequences of the activation of G-proteins
by LH are required for the cGMP decrease, and how these pathways lead to inhibition of a
guanylyl cyclase and/or activation of a cGMP phosphodiesterase in the follicle (Fig. 5).
Finally, much remains to be learned about how activation of the LH receptor causes the
synthesis of epiregulin and amphiregulin precursors and the proteolytic cleavage of these
peptides from the granulosa cell surface, leading to the activation of the EGFR (Fig. 5).
Materials and Methods
Hormones and reagents
Follicle stimulating hormone (FSH, ovine) and luteinizing hormone (LH, ovine) were
obtained from A F Parlow (National Hormone and Peptide Program, Torrance, CA).
Epiregulin and amphiregulin (mouse) were from R&D Systems (Minneapolis, MN). Alexa
Fluor 350 was from Invitrogen (#A10439, Carlsbad, CA). AG1478 and U0126 were from
EMD Chemicals (La Jolla, CA) and were dissolved in DMSO at 10 mM and 100 mM,
respectively; aliquots were stored at -80°C.
Mice and follicle culture
B6SJLF1 mice, 23-24 days old, were obtained from The Jackson Laboratories (Bar Harbor,
ME). All procedures involving mice were approved by the University of Connecticut Health
Center Animal Care Committee. The culture medium was as previously described (Norris et
al. 2008), except that the MEMα (#41061029, Invitrogen) contained no phenol red, and
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contained 3 mg/ml BSA (MP Biomedicals, Solon, OH) instead of fetal bovine serum. Antral
follicles with diameters from ~320 to ~400 μm were dissected and placed on Millicell
culture plates (PICMORG50, Millipore, Billerica, MA) with 12-16 follicles per plate, at
37°C, with 5% CO2. The follicles were cultured for 24-32 hours before use, to allow the
expression of LH receptors in response to the FSH in the medium, and to allow the follicles
to flatten on the Millicell membranes, improving their optical clarity.
Under these conditions, we could easily see the oocyte nucleus with its one or two nucleoli
through the follicle wall, by observing the culture dish from the top with a 20X/0.4 N.A.
long working distance objective (LD Achroplan #44 08 44, Carl Zeiss Inc., Thornwood,
NY) (see Fig. 2A). Follicles were checked at 24 hours after dissection, and only those that
were healthy and prophase-arrested were used for experiments. For determination of the
time course of meiotic resumption, we excluded any experiment in which <70% of control
follicles treated with LH had undergone nuclear envelope breakdown at 5 hours, since this
was considered to be an indication that unknown aspects of the culture conditions were not
optimal on that day. LH was used at a concentration of 350 nM (10 μg/ml).
cGMP ELISA assays
cGMP in follicles was assayed using an ELISA kit (#CG200, Sigma-Aldrich, St. Louis,
MO), as described by Norris et al. 2009. To prepare the samples, 12-20 follicles on a
Millicell membrane were washed twice with calcium and magnesium free PBS
(#10010-023, Invitrogen) and then transferred from the Millicell membrane to a microfuge
tube. 100 μl of 0.1 M HCl was added, and the follicles were lysed by applying ~30 pulses
with a probe sonicator (model 60, Thermo Fisher Scientific, Waltham, MA). In some cases
1% Triton X-100 was added to the 0.1 M HCl, in order to lyse the follicles more rapidly.
The samples were then heated at 95°C for 2 minutes and stored at -80°C until assayed.
The approximate cGMP concentration in the follicle was calculated based on an estimated
volume of 20 nl for the cellular space of a follicle having an average diameter of 360 μm
(Norris et al. 2009). Of the 24 nl calculated for a sphere of this diameter, a few nl are
occupied by extracellular antral space. It should also be noted that mechanically dissected
follicles have an ~10-20 μm thick layer of adhering theca cells and debris that is not part of
the follicle itself; this ~2-4 nl volume was disregarded. For these reasons, the absolute
cGMP concentrations presented in the figures and text should be considered as approximate
values.
Immunoblotting
Follicle samples for immunoblotting were prepared as previously described (Norris et al.,
2008). A431 cells treated with EGF (#sc-2202, Santa Cruz Biotechnology, Santa Cruz, CA)
were used as a positive control. Proteins were separated by SDS PAGE (7.5% gel) and
transferred to a PVDF membrane. Blots were probed with an antibody specific for pY1068
EGFR (#3777, Cell Signaling Technology, Beverly MA; 1:1,000 dilution in Tris-buffered
saline with 0.1% Tween-20 and 5% BSA) and processed for development with ECL-Plus
(GE Healthcare, Piscataway NJ). The blots were stripped with Restore Western Blot
Stripping Buffer (Thermo Fisher Scientific) and probed with an antibody for total EGFR
(#06-847, Millipore, 10 ng/ml in Tris-buffered saline with 0.1% Tween-20 and 5% BSA).
Films were scanned and the intensity of the ~170 kDa band was measured using ImageJ
software (http://rsbweb.nih.gov/ij/). Use of a different antibody against pY1068 EGFR
(#2234, Cell Signaling Technology) showed an effect on the ~170 kDa band that was similar
to that shown in Fig. 3B.
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Gap junction measurements
Gap junction permeability was assessed by microinjecting the follicle-enclosed oocyte with
2.5 mM of a 326 Da fluorescent tracer, Alexa Fluor 350, and imaging the distribution of
fluorescence in the follicle at 20 minutes after injection, using two photon microscopy (see
Norris et al. 2008). The ratio of fluorescence in the mural granulosa cells over that in the
inner cumulus cells was used as a measure of gap junction communication (see Norris et al.
2008).
Statistical analyses
Statistical analyses were performed using the Mann-Whitney test function of InStat 3 for
Macintosh (GraphPad Software, Inc., La Jolla, CA).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
cGMP in mouse ovarian follicles at various times after applying LH. Bars indicate mean ±
s.e.m., and numbers in parentheses indicate the number of samples.
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Figure 2.
Observation of the time course of nuclear envelope breakdown in intact follicle-enclosed
oocytes in response to an EGFR agonist (epiregulin), or to LH in the presence or absence of
an EGFR kinase inhibitor (AG1478). A. A mouse follicle on a Millicell membrane; the
prophase-arrested nucleus and 2 nucleoli are visible. B. Nuclear envelope breakdown at
various times after treatment of follicles with LH (350 nM), epiregulin (100 nM), or
AG1478 (500 nM) for 1 hour followed by AG1478 + LH. Numbers in parentheses indicate
the number of follicles.
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Figure 3.
cGMP in follicles under experimental conditions affecting EGFR kinase or MAP kinase
activity. A. Measurement of follicle cGMP under the following conditions: no treatment
(basal), 1 hour LH (350 nM), 1 hour epiregulin (100 nM), 1 hour AG1478 (500 nM)
followed by 1 hour AG1478 + LH, 1 hour U0126 (10 μM) followed by 1 hour U0126 + LH.
Bars indicate mean ± s.e.m., and numbers in parentheses indicate the number of samples.
The cGMP concentration after 100 nM epiregulin treatment is significantly different from
that for basal and LH conditions (p < .0001). Likewise, the cGMP concentration after
AG1478 + LH treatment is significantly different from that for basal (p < .0001) and LH (p
= .01) conditions. The cGMP concentration after U0126 + LH treatment is not significantly
different from that after LH alone (p = .7), but is significantly different from the basal
concentration (p = .0004). B. Demonstration that in follicles stimulated with LH, treatment
with 500 nM AG1478 as described above reduces EGFR phosphorylation on tyrosine 1068
to a level that is indistinguishable from the basal level without LH. 20 μg of follicle lysates,
and 2 μg of EGF-treated AG431 cells, were used for immunoblotting with an antibody
specific for pY1068 EGFR and then with an antibody specific for total EGFR. The graph
shows the ratio of the intensities of the ~170 kDa band measured with the 2 antibodies,
normalized to the no treatment condition (mean ± S.D. for 2 independent experiments).
Since the follicles were cultured for 24 hours in the absence of EGFR ligands or serum prior
to preparing the samples, the basal signal seen with the pY1068 antibody is probably not due
to EGFR kinase activity; it could result from phosphorylation of the EGFR by other kinases
or to cross-reactivity of the antibody with non-phosphorylated EGFR.
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Figure 4.
Gap junction communication in follicles under experimental conditions affecting EGFR
kinase activity. Gap junction communication was assessed by injecting the oocyte with
Alexa Fluor 350 and imaging the follicle 20 minutes later. A. Images of follicles that were
treated as follows prior to injection of the fluorescent tracer: no treatment (basal), 1 hour LH
(350 nM), 1 hour epiregulin (100 nM), 1 hour epiregulin (1 μM) + amphiregulin (1 μM), 1
hour AG1478 (500 nM) followed by 1 hour AG1478 + LH. B. Ratios of fluorescence in the
mural granulosa cells over that in the inner cumulus cells (MG/IC), at 20 minutes after
injection, for each of the conditions indicated in A. Bars indicate mean ± s.e.m., and
numbers in parentheses indicate the number of follicles. The MG/IC ratio after treatment
with 100 nM epiregulin is significantly different from that after LH (p = .05), and from the
basal ratio (p = .005). Likewise, the MG/IC ratio after treatment with 1 μM epiregulin + 1
μM amphiregulin is significantly different from that after LH (p = .0003); the difference
from the basal ratio is marginally significant (p = .06). The MG/IC ratio for AG1478 + LH
is significantly different from that for LH (p < .0001), but not from the basal ratio (p = 1.0).
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Figure 5.
Some of the known and unknown components of the signaling network linking LH receptor
and EGFR receptor activation in the granulosa cells to the decrease in cGMP in the oocyte
that leads to resumption of meiosis.
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